Thus, in addition to its effect on tumour cells, PTPN2/N1 inhibition enhances T cell activation, consistent with previously reported effects of genetic ablation of PTPN2 or PTPN1. However, dual inhibition of both phosphatases with AC484 more potently promoted T cell activation than single targeting approaches. The gene discussed is PTPN2; the disease is neoplasm.